Back to Search
Start Over
RETRACTED: Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer.
- Source :
-
Cancer letters [Cancer Lett] 2018 Oct 10; Vol. 434, pp. 1-10. Date of Electronic Publication: 2018 Jun 30. - Publication Year :
- 2018
-
Abstract
- This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Upon investigation, it was discovered that 5 figures contain fabrication. Figures 1C, 3D, 5C, 5D, and 6G contain manipulated and/or duplicated data. The authors requested a corrigendum be published, however, due to the large number of corrections applied (figures 3, 6, 7, 8 and S3), it cannot be concluded that these changes would not alter the conclusions of the paper. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.<br /> (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Antineoplastic Agents, Hormonal pharmacology
Breast Neoplasms genetics
Breast Neoplasms pathology
Cell Survival drug effects
Cell Survival genetics
Down-Regulation
Drug Resistance, Neoplasm genetics
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Kaplan-Meier Estimate
MCF-7 Cells
Mice, Nude
Breast Neoplasms drug therapy
Drug Resistance, Neoplasm drug effects
MicroRNAs genetics
RNA, Long Noncoding genetics
Tamoxifen pharmacology
Xenograft Model Antitumor Assays methods
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7980
- Volume :
- 434
- Database :
- MEDLINE
- Journal :
- Cancer letters
- Publication Type :
- Academic Journal
- Accession number :
- 29969658
- Full Text :
- https://doi.org/10.1016/j.canlet.2018.06.039